Wird geladen...
21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer
BACKGROUND/PURPOSE: The 21-gene recurrence score (RS) assay evaluates the likelihood of distant recurrence and benefit of chemotherapy in lymph node-negative, estrogen receptor (ER)-positive, HER2-negative breast cancer patients. The RS categories are associated with the risk of locoregional recurre...
Gespeichert in:
| Veröffentlicht in: | Breast Cancer Res Treat |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5647226/ https://ncbi.nlm.nih.gov/pubmed/28702894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4381-7 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|